Hochschulschrift
Amyloid beta 4-42 in Alzheimer’s disease: Target, Therapy, Mechanism
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Göttingen, Georg-August Universität, Diss., 2016
- Keyword
-
Hirnkrankheit
Neuropsychiatrie
Nervenkrankheit
- Event
-
Veröffentlichung
- (where)
-
Göttingen
- (who)
-
Niedersächsische Staats- und Universitätsbibliothek Göttingen
- (when)
-
2016
- Creator
-
Antonios, Gregory
- Contributor
-
Bayer, Thomas A.
Jarry, Hubertus
Dresbach, Thomas
- Handle
-
11858/00-1735-0000-0028-8731-6
- URN
-
urn:nbn:de:gbv:7-11858/00-1735-0000-0028-8731-6-8
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:54 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Associated
- Antonios, Gregory
- Bayer, Thomas A.
- Jarry, Hubertus
- Dresbach, Thomas
- Niedersächsische Staats- und Universitätsbibliothek Göttingen
Time of origin
- 2016
Other Objects (12)
Cellular mechanism of amyloid formation in Alzheimer’s disease and systemic AA amyloidosis
Alzheimer’s disease: Amyloid oligomers, therapeutic agents, their target and mode of action
β-amyloid in Alzheimer’s disease initiation and phenotypic diversity
Alzheimer's disease: amyloid oligomers, therapeutic agents, their targets, and mode of action
Monitoring Alzheimer Amyloid Peptide Aggregation by EPR
Die cerebrale Amyloid-Angiopathie der Alzheimer-Krankheit
The role of amyloid beta 4-42 in the etiology of Alzheimer's disease
Cellular Receptors of Amyloid β Oligomers (AβOs) in Alzheimer’s Disease
Initial Aβ seeds as therapeutic target for Alzheimer’s disease
Selektion hochaffiner RNA-Moleküle gegen das Alzheimer β-Amyloid [Beta-Amyloid]
Selektion hochaffiner RNA-Moleküle gegen das Alzheimer β-Amyloid [Beta-Amyloid]
Modifikation der zellulären Expression des Alzheimer-β-Amyloid-Precursor-Proteins [Alzheimer-beta-Amyloid-Precursor-Proteins] (APP) durch ionisierende Strahlung
Cellular mechanism of amyloid formation in Alzheimer’s disease and systemic AA amyloidosis
Alzheimer’s disease: Amyloid oligomers, therapeutic agents, their target and mode of action
β-amyloid in Alzheimer’s disease initiation and phenotypic diversity
Alzheimer's disease: amyloid oligomers, therapeutic agents, their targets, and mode of action
Monitoring Alzheimer Amyloid Peptide Aggregation by EPR
Die cerebrale Amyloid-Angiopathie der Alzheimer-Krankheit
The role of amyloid beta 4-42 in the etiology of Alzheimer's disease
Cellular Receptors of Amyloid β Oligomers (AβOs) in Alzheimer’s Disease
Initial Aβ seeds as therapeutic target for Alzheimer’s disease
Selektion hochaffiner RNA-Moleküle gegen das Alzheimer β-Amyloid [Beta-Amyloid]
Selektion hochaffiner RNA-Moleküle gegen das Alzheimer β-Amyloid [Beta-Amyloid]
Modifikation der zellulären Expression des Alzheimer-β-Amyloid-Precursor-Proteins [Alzheimer-beta-Amyloid-Precursor-Proteins] (APP) durch ionisierende Strahlung
Cellular mechanism of amyloid formation in Alzheimer’s disease and systemic AA amyloidosis
Alzheimer’s disease: Amyloid oligomers, therapeutic agents, their target and mode of action
β-amyloid in Alzheimer’s disease initiation and phenotypic diversity
Alzheimer's disease: amyloid oligomers, therapeutic agents, their targets, and mode of action
Monitoring Alzheimer Amyloid Peptide Aggregation by EPR
Die cerebrale Amyloid-Angiopathie der Alzheimer-Krankheit
The role of amyloid beta 4-42 in the etiology of Alzheimer's disease
Cellular Receptors of Amyloid β Oligomers (AβOs) in Alzheimer’s Disease
Initial Aβ seeds as therapeutic target for Alzheimer’s disease
Selektion hochaffiner RNA-Moleküle gegen das Alzheimer β-Amyloid [Beta-Amyloid]
Selektion hochaffiner RNA-Moleküle gegen das Alzheimer β-Amyloid [Beta-Amyloid]